Avidity Partners Management LP Xenon Pharmaceuticals Inc. Transaction History
Avidity Partners Management LP
- $445 Million
- Q1 2025
A detailed history of Avidity Partners Management LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 229,000 shares of XENE stock, worth $7.17 Million. This represents 1.73% of its overall portfolio holdings.
Number of Shares
229,000
Previous 474,000
51.69%
Holding current value
$7.17 Million
Previous $18.6 Million
58.65%
% of portfolio
1.73%
Previous 2.1%
Shares
9 transactions
Others Institutions Holding XENE
# of Institutions
220Shares Held
70.2MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$180 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$144 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$119 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$104 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$96.8 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $1.95B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...